VTA-27

N/A

Report date: 2025/01/17 17:55:38
NME

Base Information

Drug NameVTA-27
Drug Alias NameVTA-27VT-N
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAnti-TAU
TargetsMicrotubule-associated protein tau
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVasThera Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesVasThera Co Ltd
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A